Loading...
Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation
Small cell lung cancer (SCLC) is the most aggressive type of lung cancer with high mortality. One of the MYC family genes, MYC, MYCL or MYCN, is amplified in ~20% of the SCLCs; therefore, MYC proteins are potential therapeutic targets in SCLC patients. We investigated the therapeutic impact of Omomy...
Na minha lista:
Udgivet i: | Oncotarget |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Artigo |
Sprog: | Inglês |
Udgivet: |
Impact Journals LLC
2016
|
Fag: | |
Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5058735/ https://ncbi.nlm.nih.gov/pubmed/27105536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.8826 |
Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|